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SUMMARY
Purpose: To gain new insights into the clinical presenta-
tion, causes, treatment and prognosis of epilepsia partialis
continua (EPC), and to develop hypotheses to be tested in
a prospective investigation.
Methods: In this retrospective multicenter study, all cases
were included that fulfilled these criteria: constantly
repeated fragments of epileptic seizures, with preserved
consciousness, lasting ‡1 h and representing locally
restricted motor or sensory epileptic activity. Single epi-
sodes were included when they lasted for a minimum of
1 day. EPC with Rasmussen syndrome and acute stroke
were excluded.
Key Findings: Three time courses with two subtypes each
were distinguished, that is, EPC as a solitary event (de
novo or in preexistent epilepsy); chronic repetitive non-
progressive EPC (with frequent or rare episodes); and
chronic persistent nonprogressive EPC (primarily or
evolving out of an episodic course). These were unrelated
to etiologies (morphologic lesions 34%, inflammatory
29%, systemic disorders 9%, idiopathic 5%, unknown 23%).
Precipitation and inhibition of seizures is a frequent fea-
ture of EPC. Levetiracetam and topiramate have
improved the possibilities for pharmacotherapy. Topira-
mate seems to be particularly effective with dysontoge-
netic etiologies.
Significance: The existence of several clearly distinct
courses of nonprogressive EPC is a new finding. These dis-
tinctions will be further investigated in a prospective study
with precise protocols for electroencephalography (EEG),
imaging, and other studies. This should better establish
the relation of motor and somatosensory EPC; further
clarify the relations, pathogenesis, and significance of the
different types and their etiologies; and possibly identify
more semiologic variants. It should also provide more
precise knowledge about therapy and modification of icto-
genesis by external stimuli.
KEY WORDS: Epilepsia partialis continua etiologies,
Nonprogressive epilepsia partialis continua, Sensory epi-
lepsia partialis continua, Focal status epilepticus, Aura
continua, Developments of epilepsia partialis continua.
Epilepsia partialis continua (EPC) was first described,
and the term proposed by Aleksei Yakovlevich Kozhevni-
kov (1836–1902), in a report on ‘‘a special form of cortical
epilepsy’’ to the Russian Society for Neuropathology and
Psychiatry on January 21, 1894 (Kozhevnikov, 1895). He
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described four cases of uninterrupted local cloni and pro-
posed to call the condition ‘‘epilepsia partialis continua.’’ In
the discussion Dr. Minor reported similar observations, the
symptoms in one case being sensory for which he suggested
the term ‘‘aura continua.’’ When Kozhevnikov disagreed,
Dr. Filatov proposed as a compromise to call the condition
‘‘Kozhevnikov’s epilepsy.’’ Interestingly, all three terms
came and still are in use.
EPC has been described in a great variety of clinical con-
texts and etiologies (Wieser & Chauvel, 2008). Among
these, the chronic-progressive inflammatory Rasmussen
syndrome (Dubeau et al., 2008) is today considered an own
nosologic entity and will not be discussed here. Another
well-known relation is to the acute phase of stroke (Sinha &
Satishchandra, 2007).
Beyond two old (Thomas et al., 1977; Cockerell et al.,
1996) and two more recent (Gurer et al., 2001; Sinha & Sat-
ishchandra, 2007) reviews of larger case series, little effort
has been taken to further investigate and map EPC. In par-
ticular, knowledge is insufficient about variations in the pre-
sentation, course, and development of EPC, and relations to
other seizure types, causative factors, syndromatic aspects,
and response to therapy.
Following the London Status Epilepticus Symposium of
2007 (Shorvon et al., 2007), an informal study group of
European centers was formed to address these questions.
Twenty-one cases from nine centers were collected and pre-
sented at the 2nd European Status Epilepticus Symposium
(Wolf et al., 2009). In response, 10 additional centers joined
the study group, and recruitment was extended until Sep-
tember 30, 2009, where 65 cases were enrolled. These are
presented here. The aims of this study are to get new insights
into the clinical presentation, causes, treatment, and progno-
sis of EPC, and to develop hypotheses to be tested in a pro-
spective investigation.
Material and Methods
In this retrospective multicenter study, no attempts were
made to systematize the case collection. All cases were
included that fulfilled the definition below and had no indi-
cation of having Rasmussen encephalitis or being acute
symptoms of stroke, both conditions appearing to be suffi-
ciently described already. Some participating groups had
internally registered EPC cases in view of possible publica-
tion; others had not. Both neurologic and pediatric groups
participated.
Definitions
There is at present no generally accepted definition of
EPC. Thomas et al. (1977) proposed one hour as the mini-
mum duration of a condition to be accepted as EPC, with
regular or irregular muscular twitches affecting a limited
part of the body and recurring at intervals not above 10 s.
Maximum intervals, however, are not generally included in
the definition (Obeso et al., 1985; Cockerell et al., 1996),
and a shorter minimum duration (30 min) was proposed by
Wieser and Chauvel (2008). These definitions apply to
motor EPC, to which many authors restrict the term, not dis-
cussing, however, where to draw the line to somatosensory
symptoms that often occur together with motor signs or as
an isolated symptomatology (Penfield & Jasper, 1954; Janz,
1969). If somatosensory aura continua is included, should
not other types of aura continua also be considered, for
example, visual (Palem et al., 1970; Wolf, 1980), auditory
(Wolf, 1983), gustatory (Wieser et al., 1985; Seshia &
McLachlan, 2005), and olfactory (Wolf, 1982; Manford &
Shorvon, 1992), distortion of proprioception (Scott & Mas-
land, 1953), epigastric and autonomic (Scott & Masland,
1953; Wolf, 1980), dysmnesic (Wolf, 1980), and anxiety
(Scott & Masland, 1953; Henriksen, 1973)? In some of
these, the distinction from nonconvulsive, complex partial
status can be difficult as was discussed by Wieser and
Fischer (2009) and Chicharro and Kanner (2009). Another
case is aphasia or dysphasia caused by epileptic status activ-
ity (De Pasquet et al., 1976), where it is difficult to deter-
mine if it is an ictal or, rather, postictal symptom (Wieser &
Chauvel, 2008).
Penfield & Jasper, (1954, p. 37) found it ‘‘justifiable to
extend the meaning of the term to cover any type of focal
seizure which is continuous without spreading to a larger
seizure or with only occasional spread.’’We agree.
For the purpose of this study we defined EPC [in distinc-
tion from simple focal status epilepticus (SE) with fre-
quently recurring, but still distinguishable separate seizures]
as a condition of continuously repeated fragments of epilep-
tic seizures (motor or sensory), with preserved conscious-
ness, lasting ‡1 h, and representing locally restricted
epileptic activity. Our inclusion criteria were pragmatic: we
included cases with focal motor or sensory symptoms, and
excluded less clearly delineated conditions, that is, psychic,
autonomic, and cognitive types of aura continua, and dys-
phasic SE. Single episodes were included when they lasted
for a minimum of 1 day.
Results
For a patient overview see Table 1. Three types of devel-
opment could be distinguished in our cohort, that is:
1. EPC as a solitary event
2. Chronic repetitive nonprogressive EPC
3. Chronic persistent nonprogressive EPC
EPC was rated as persistent when in the reported period
it was present daily, whereas shorter interruptions, for
example during sleep, were accepted.
Type 1 was reported in 12 cases of different etiology and
pathogenesis, both de novo (n = 7), and in established epi-
lepsy (n = 5, Table 2). The episodes lasted from 4 days to
3 months, except for one patient with EPC due to probable
herpes simplex encephalitis who died after 36 h.
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Type 2 was found in 18 cases. This pattern persisted until
inclusion, having been present for up to 29 years. This type
seems not to be homogeneous but to split into two
subgroups. In the first (2a, ‘‘frequent,’’ n = 10), the single
episodes of EPC lasted not longer than 24 h and occurred
more than once per month. In the other subgroup (2b,
‘‘rare,’’ n = 8) the single episodes lasted several days up to
some weeks and occurred at longer intervals of typically
several months. Within one episode of type 2b, the EPC
could be fully continuous or present with brief interruptions.
Both patterns remained stable over periods up to 29 (2a) and
25 years (2b), respectively.
Type 3 was described in 35 cases, lasting from 1–
25 years. In seven of these, EPC started with episodes (three
type 2a and four type 2b) and after 3 months to 4 years sec-
ondarily evolved into the persistent type. The reverse course
was seen only once—not as a spontaneous evolution but as
a partial effect to therapy with tiapride.
EPC was rarely the only manifestation of epilepsy (8 of
65). The concomitant seizure types were simple focal in 45
cases, secondarily generalized tonic–clonic in 30, and com-
plex partial in 15. The values add up to >65, since many
patients had more than one, and one had multiple seizure
types. Three had a history of convulsive status epilepticus,
Table 1. Patient overview
All
N = 65
Type 1
Single episode
N = 12
Type 2
Episodic recurrent EPC
N = 18
Type 3
Persistent EPC
N = 35
Age in years
(mean ± SD)
2–70 (27.4 ± 19.5) 2–66 (27.2 ± 24.3) 6–70 (31.8 ± 21.7) 6–63 (25.2 ± 16.5)
Sex: men/women 37/28 6/6 8/10 23/12
Duration of EPC
(mean years ± SD)
6.5 ± 6.5 36 h–3 months 8.4 ± 9.2 6.2 ± 4.8
Age at onset of epilepsy
(mean ± SD)
5 month–68 year
(16.8 ± 18.9)
5 month–66 year
(21.6 ± 26.8)
9 month–68 year
(18.3 ± 19.6)
6 month–60 year
(14.4 ± 15.2)
Age at onset of EPC
(mean ± SD)
6 month–69 year
(22.3 ± 20.0)
1–66 year
(27.4 ± 26.8)
2–69 year
(22.7 ± 21.0)
4–60 year
(20.0 ± 16.5)
Interval from onset
epilepsy to EPC
(mean ± SD)
)2–28 year
(4.3 ± 6.8)
0–22 year
(6 ± 7.9)
0–15 year
(3.2 ± 5.3)
)2–28 year
(4.1 ± 7.1)
Etiologies
Morphologic lesions
FCD 9 (13.8%) 1 3 5
Tumor incl. DNT 4 (6.2%) 1 1 2
AVM, cavernoma 2 (3.1% 0 0 2
Postoperative/trauma 2 (3.1%) 0 0 2
Subdural hematoma 1 (1.5%) 0 1 0
Unspecified lesion 3 (4.6%) 0 1 2
Vascular lacunae 1 (1.5%) 0 0 1
Inflammatory
Tick-borne encephalitis 9 (13.8%) 0 0 9
Herpes simplex encephalitis 1 (1.5%) 1 0 0
Nonspecific 7 (10.8%) 1 3a 3
Creutzfeldt-Jacob disease 2 (3.1%) 2 0 0
Systemic
Morbus Alpers 5 (7.7%) 0 1 4
MELAS 1 (1.5%) 0 0 1
Idiopathic
BECTS 3 (4.6%) 1 2 0
Unknown 15 (23.1%) 5 6 4
aOne of these, a 41-year-old woman with frequently repeated episodes of motor EPC starting at age 28 and on brain biopsy diagnosed as atypical Rasmussen
encephalitis has meantime been histologically rerated as Rasmussen encephalitis, adult form.
Table 2. Single episodes of EPC with etiologies or
pathogenesis (type 1, n = 12)
1. In preexisting epilepsies
a. Sleep deprivation, stress in cryptogenic focal epilepsy
b. Anterior opercular syndrome, CSWS in idiopathic rolandic epilepsy
c. Encephalitis (suspected herpes simplex) in cryptogenic focal epilepsy
d. Epilepsy with focal cortical dysplasia, reduction of valproate, and
oxcarbazepine after seizure control
e. Side effect of zonisamide treatment of resistant multifocal epilepsy
2. De novo
a. Local encephalitis after biopsy of oligodendroglioma
b. HHE syndrome, initial phase of hemiconvulsions
c. Systemic infectious disease
d. Creutzfeldt-Jacob disease (2)
e. Unclarified (2)
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and one was in addition to epilepsy diagnosed with psycho-
genic nonepileptic seizures. When the habitual seizures had
a clear focal onset, the semiology of the EPC could always
be recognized as a seizure fragment. This was not possible
in cases where EPC was the only clinical manifestation,
when the patient had generalized tonic–clonic seizures with-
out clinical focal onset, and in the case of systemic diseases
and multiple seizure types.
The majority of patients (49 of 65) had the motor type of
EPC, and in seven the symptoms were reported as sensori-
motor. Five patients had somatosensory EPC and four had
visual EPC.
Clinical presentation
In motor and sensorimotor EPC, the symptoms were
restricted to a narrow localization, sometimes just one mus-
cle, in 18 cases, and involved a whole limb in 7. In 24, the
distribution was unilateral, although more expanded,
involving more than one limb. In 10 patients (seven bilat-
eral) there were indications of more than one focus produc-
ing EPC.
The local distribution is shown in Table 3. Face and
upper extremity are predominantly affected.
Findings
Neurologic findings (Table 4) are present in most cases,
demonstrating that EPC predominantly is a symptom of
brain pathologies that go beyond mere dysfunction. How-
ever, at least in five patients the deficits were transient
(Todd paresis), and in cases of type 3 with very frequent
motor symptoms it can be impossible to distinguish irrevers-
ible damage from a permanent postictal state—unless a suc-
cessful treatment is eventually found and the symptoms
remain or resolve. Twenty patients (30.8%) had no neuro-
logic deficit, indicating that EPC may also be the sign of a
merely functional disturbance.
EEG
EEG investigations, usually repetitive, were a consistent
part of the diagnostic work-up in all cases but did not follow
a uniform protocol. We tried to distinguish between interic-
tal EEG, ictal EEG of individual seizures (if applicable),
and ictal EEG during EPC but in retrospect this was often
not possible. Interictal EEGs always exists, but ictal record-
ings of seizures or of EPC were not always obtained. When
the information from interictal state, single seizures, and
EPC is summarized, including only the most specific find-
ing of each patient, epileptiform activity was found in 42
cases (64.6% of all cases, 8 in type 1, 13 in type 2, and 21 in
type 3), slow waves in 11 cases (two each in types 1 and 2,
and seven in type 3), and local flattening in one case of type
3. The EEG was unrevealing in only 11 patients (two of type
1, three of type 2, six of type 3).
Imaging
The etiologies as presented in Table 1 are based upon a
multitude of different modalities and protocols of various
imaging methods that were applied in 62 patients (95.4%).
Some of these were very advanced, others of less reliable
expertise. Various focal abnormalities (see Table 1) were
found in 50 cases (80.6%) and all of them corresponded to
seizure semiology. In 37 cases (56.9%) only magnetic reso-
nance imaging (MRI) was performed, with positive findings
in 30. Ten patients (15.4%) were investigated by computed
tomography (CT) and MRI with positive findings in six of
which in four only MRI showed pathology. CT scan only
was applied in three patients with positive findings in two.
MRI and single photon emission computed tomography
(SPECT) were performed in three cases and pathology was
found in all three (in two only in SPECT); CT, MRI, and
SPECT were performed in three cases, two of which had
positive findings only with SPECT. In one patient, only
SPECT was applied with a positive result. In three patients,
pathology was revealed only when more methods were
combined [CT + MRI + angiography; MRI + positron
emission tomography (PET); MRI + SPECT + PET (pub-
lished by Siclari et al., 2009) in one each]. In three patients,
all with tick-borne encephalitis, no imaging investigations
were done because they were seen in a far-Eastern rural
areas of Russia where these methods were not available.
Table 3. Local distribution of EPC (without visual
EPC, n = 61)
Face 15
Face and arm 16
Arm/hand 11
Arm and leg 2
Leg/foot 7
Hemibody 6
2 Loci 4
Table 4. Neurologic findings
Mild hemiparesis 7
Hemiparesis 13
Monoparesis foot 2
Hemiparesis and -anopia 1
Monoparesis hand 4
Anterior opercular syndrome and aphasia/dysphasia 2
Facial paresis 2
Hemiparesis and ataxia 1
Hemiparesis and aphasia 3
Hemiparesis and sopor 1
Blindness, learning disabilities 1
Ataxia 2
Mild mental retardation 1
Rapid deterioration 3
Todd’s paresis 5
Speech arrest 1
Visual field defect 2
None 20
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Etiology and pathogenesis
The etiologies (see Table 1) could be clarified in 50 cases
(76.9%). Local morphologic lesions were demonstrated in
21, and one 63-year-old patient had multiple vascular lacu-
nae. Nineteen patients had inflammatory etiologies includ-
ing nine cases of tick-borne encephalitis. Six patients had
systemic disorders (five with morbus Alpers including a sib-
ship of two, and one with mitochondrial encephalomyo-
pathy, lactic acidosis and stroke-like episodes [MELAS]).
Three patients had idiopathic rolandic epilepsy of child-
hood, which in two was complicated by continuous spikes
and waves during slow sleep (CSWS) and anterior opercular
syndrome, whereas in the third (followed until age 18) inter-
mittent episodes of EPC with numbness in the tip of tongue,
right angle of mouth, and fingertips accompanied by epilep-
tiform EEG activity were the only unusual feature in an
otherwise perfectly benign course, the patient being totally
seizure free and without drugs since age 12.
The pathogenesis was apparent in most type 1 cases
(Table 2) but less often in the other types. Of the 18 type 2
cases, the pathogenesis of the first or several episodes could
be defined in 5 and was different in each [intracranial hema-
toma; tumor resection; period of increased seizure activity;
prolonged aura of secondary generalized tonic–clonic sei-
zures (GTCS); presenting symptom of unknown etiology].
In all others the development of EPC seemed for reasons not
clearly identified to be part of the evolution of the epilepsy.
Of the 35 chronic persistent cases, EPC was the presenting
symptom in 10, and caused by antiepileptic drug (AED)
withdrawal in one. In nine cases the etiology was tick-borne
encephalitis, where EPC in eight started with an interval of
4 weeks to 2.5 years after the acute meningoencephalitis,
and in one case, 3 months after a tick bite without an acute
inflammatory phase.
Therapy
EPC is known as a condition that is difficult to treat.
Like other status types, it could often be interrupted by
benzodiazepines. To reach sustained effect, a multitude
of AEDs were applied, often without success. Treatments
that were found to stop or at least alleviate EPC usually
did it only in individual cases (Table 5). Apart from sev-
eral cases where benzodiazepines temporarily interrupted
the EPC, two AEDs presented a better success rate. To-
piramate was effective in 7 of 28 cases where it was
tried, and patients with a dysontogenetic etiology of EPC
(four cortical dysplasias and one arteriovenous malforma-
tion) seemed to respond best. Levetiracetam was given to
26 patients and was successful in 8. These included five
patients with inflammatory etiologies (three with tick-
borne encephalitis; one with oligodendroglioma and peri-
neoplastic inflammation; and one with chronic local
encephalitis, which is now considered an atypical adult-
onset case of Rasmussen encephalitis). In six cases of
different etiologies, treatment with steroids was success-
ful, in two of these, however, given in combination with
clonazepam. Successful treatment of EPC not necessarily
was also effective against the patient’s individual sei-
zures.
Precipitation and inhibition of ictal activity
In 24 of our patients (36.9%) trigger mechanisms were
observed either for precipitation of individual seizures (5)
or for increase of EPC (19). This feature was found in 16 of
49 with motor, 4 of 7 with sensorimotor, 3 of 5 with somato-
sensory, and 1 of 4 with visual EPC. The trigger mecha-
nisms were motor action in 12, touch in 9, passive
movement in 2, and intention to move, ‘‘mental exercise,’’
light and noise in one each (more than one trigger was
present in two cases; exposure to light was a trigger of visual
seizures in a patient who developed visual EPC). Modula-
tion of EPC intensity by motor or sensory input was
described in seven of the nine cases with motor EPC due to
tick-borne encephalitis, and in the same cases it was
reported that physical and emotional rest reduced EPC.
More specific external inhibition of EPC was reported in
four cases, one each by relaxation, by passive immobiliza-
tion of the convulsing limb, or to the contrary by its strong
innervation; touching a trigger zone in one patient could
either inhibit the development of sensory EPC or precipitate
a tonic seizure, depending on the timing of the stimulus.
One patient reported self-inhibition of spread of focal motor
seizures by deep relaxation at seizure onset.
Discussion
In this study, three different time courses of EPC were
represented: solitary event (type 1), chronic repetitive non-
progressive (type 2), and chronic persistent nonprogressive
(type 3). Chronic progressive EPC, or Rasmussen syn-
drome, can be added as type 4 but was not part of this inves-
tigation as it is already well-described.
Type 1
This type is probably underrepresented in this survey due
to ascertainment bias and because stroke, one important eti-
ology, was excluded from the collection since it appeared
already well-described. Two subgroups could be distin-
guished: 1a single episodes of EPC in preexisting epilepsies
and 1b acute symptomatic EPC. Stroke is the best-known
etiology in 1b but there are many others. Factors condition-
ing EPC in established epilepsies should be studied system-
atically and prospectively. The factors observed here
include sleep deprivation and changes in antiepileptic drug
treatment, that is, well-known facilitating factors of seizures
and, in particular, status epilepticus. The question remains
open, why in these cases they resulted in EPC. Notably, by
far the most common accompanying seizure type in our
patients was simple focal. This seems to indicate that strong
inhibition of seizure spread is a general feature of the
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ictogenesis in these patients, which may also be expressed
in the manifestation of EPC.
A caveat about single episodes of EPC in a cross-sec-
tional survey is that they could represent first episodes of
type 2, especially if no clear etiology can be defined. To
clarify this prognostic question will be one of the tasks for a
prospective study.
Type 2
Again, two clearly separated subtypes appeared: 2a, with
frequent brief episodes; and 2b, with rare long episodes. The
two patterns did not overlap or alternate in any patient, and
remained the same over periods of up to >20 years, indicat-
ing that they do not represent opposite ends of a continuum
but separate pathogenic mechanisms. In subtype 2a EPC
Table 5. Successful treatments
EPC
type
Successful
treatment
(N)
Successful
medication
(*-partial effect)
Etiology of
EPC Failed medications
Type 1
(single period)
1 TPM Unknown VPA, LEV, PHT, MDZ, PB
1 TPM + OXC* FCD VPA, CZP, LTG, OXC, LEV, TPM
1 VPA + OXC* FCD –
1 LEV Tumour –
2 NZP* Unknown VPA, BZD, VGB, LTG
1 CZP + steroids Idiopathic VPA, LEV, CZP
1 PGB Unknown LEV, PHT, CZP
Type 2
(episodic recurrence)
1 TPM FCD CBZ, CLB, CZP, PHT, LTG, MZD, PGB, PRM, TPM
1 LEV FCD LZP, DZP, CZP, PHT, VPA, TPM, PB, CBZ, Thiopental
1 LEV* FCD TPM, LTG, STM, OXC, CBZ, VPA
1 OXC* Unspecified
lesion
CBZ, VPA
1 VNS* Unknown All
1 CBZ + VPA FCD –
1 VNS (50%),
LEV, BZD*
Nonspecific
encephalitis
CBZ, VPA, PGB, LTG
1 LEV* Tumor LTG, CBZ, CLB, VPA, PHT, LZM
1 Steroids + CZP* Idiopathic VPA, LEV, OXC
1 Steroids Unknown VPA, VGB, CBZ, PB, TPM, LTG, CLB, NZP, CZP
1 VPA* Nonspecific
encephalitis
PB, OXC, LEV
1 LTG Traumatic LTG, VPA, PHT, CBZ, LEV
Type 3
(persistent)
2 TPM FCD CBZ, CLB, CZP, PHT, GBP, LTG, MDZ, OXC,
PB, PRM, VPA, VGB
1 PB Tumor CBZ, VPA, TPM, LEV
1 TPM Postoperative OXC, PGB, VPA, CBZ
1 TPM FCD CBZ, CLB, CZP, PHT, LEV, LTG, PB, PRM, VPA, VGB
1 CZP* Postoperative CBZ, PHT, VPA, PB, TPM, OXC, LTG, PHT
1 CBZ + TPM Unknown VPA, PRM, PB, CBZ, CZP, LTG
2 Steroids* FCD Several
1 LTG + GBR +
Tiapridex*
Encephalitis CBZ, CZP, CLB, VPA, LEV, PHT, NZP, LZP
1 Steroids +
Plasmapheresis*
Nonspecif.
encephalitis
CBZ, VGB, PHT, GBP, VPA, LTG, ESM, PRM, STM,
LEV, OXC, TGB
1 ESM + VGB* Morbus Alpers PHT, DZP, CZP, VPA, PB, THIOPENTAL, MDZ,
OXC, BRV, LEV, VGB, CLB, ESM,
prednisolone, lidocaine
1 VGB* FCD CBZ, OXC, PHT, PB, VPA, LEV, TPM, GBP, LTG
1 Surgery* Cavernoma CBZ, GBP, LTG, LEV, TPM, VPA
1 LEV* TBE VPA, CBZ, LTG, CZP, DZP
1 CZP* TBE CBZ
1 VPA + PB* TBE CBZ, VPA
1 VPA + LEV* TBE VPA, LTG, TPM
1 LEV* TBE CBZ, CZP, DPH, prednisolone
1 LTG + VGB* MELAS CBZ, VPA, PB, PHT, GBP, CLB
BRV, brivaracetam; BZD, benzodiazepines; CLB, clobazam; CZP, clonazepam; DZP, diazepam; ESM, ethosuccimide; LEV, levetiracetam; LTG, lamotrigine; LZM,
lacozamide; LZP, lorazepam; MDZ, midazolam; NZP, nitrazepam; OXC, oxcarbazepine; PB, Phenobarbital; PGB, pregabalin; PHT, phenytoin; PRM, primidone;
STM, sulthiam; TGB, tiagabin; TPM, topiramate; VGB, vigabatrin; VPA, valproic acid.
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looks like a type of seizure with unusually long duration,
whereas subtype 2b could be related to periodic or epi-
sodic changes in seizure susceptibility. Interestingly, both
subtypes could develop into type 3. An important task for
the prospective study will be to confirm these subtypes and
better understand their pathogenesis.
Type 3
There are again two subgroups: 3a, starting as type 2; and
3b, immediately persistent; but the subgroups do not look
fundamentally different. It is not known at present if this dif-
ference has any particular significance. Type 3 was seen
with all etiologies, whereas it was the only type connected
with tick-borne encephalitis. Here it started with a delay of
4 weeks to 2.5 years (mean 10 months). Although the
persisting type in seven cases evolved from recurrent
episodes of EPC, it was in 8 of 35 cases already part of the
presenting symptomatology. In one of three cases where the
pathogenesis of EPC was related to changes in AED treat-
ment (discontinuation of carbamazepine [CBZ] by patient),
the EPC persisted and has now lasted 20 months.
Clinical presentation and diagnosis
The symptoms of EPC are likely to reflect epileptic activ-
ity restricted to the ictal-onset zone, and are categorically
identical with the first signs and symptoms of the patients’
individual seizures. However, this is not always easy to rec-
ognize, especially when the latter habitually are brief, unim-
pressive, or merely subjective. The continuous repetition of
such seizure fragments can create clinical pictures that are
little suggestive of epilepsy and, therefore, difficult to rec-
ognize. Depending on the location and connectivity of the
focus, motor symptoms can be rather widespread, synchro-
nously involving groups of muscles, a whole limb, or even
an entire body half. These will not go unnoticed. But nar-
rowly localized continuous minimal myocloni, which the
patients often fail to report, may be missed, especially when
the attention is focused on more obvious seizure types. The
twitches may escape inspection and only be revealed by
touching the affected area. The same can happen in the rare
cases when EPC is the first or only manifestation of epi-
lepsy. Epilepsy essentially is a disorder of seizures, and con-
tinuous or quasicontinuous symptoms are an unexpected
presentation.
Then, as already noted by Gowers (1881), the sensory
cortex and motor cortex in epilepsy typically interact clo-
sely, and the motor signs of both individual Jacksonian
seizures and EPC are often accompanied by paresthesias
or numbness (Janz, 1969). Likewise, somatosensory sei-
zures are frequently followed by motor phenomena
(47.4% according to Mauguire & Courjon, 1978). How-
ever, this feature is rarely mentioned in the literature, and
in this retrospective series we cannot be sure that the
symptoms were not sensorimotor more frequently than in
seven cases.
Merely somatosensory EPC is even more difficult to rec-
ognize and may often be missed. Therefore, the repetitive
local paresthesias in the patient of Wolf and Dockweiler
(1989), who is included in this study, would not have
been diagnosed as EPC without their indispensible and
quantitative role as a precondition for the reflex epileptic
response, with focal tonic seizures, to touch in the area.
Fundamentally, in cases of somatosensory EPC, it would
be necessary to monitor electromyographic activity to
exclude subtle motor involvement. To establish the true
relation of motor, sensorimotor, and somatosensory EPC is
another point that needs to be addressed in the prospective
investigation.
In other instances the diagnosis can be based upon the
development of the clinical condition, such as in one case
with a dysontogenetic tumor in the left sulcus frontalis supe-
rior, where ictal dysesthesias of the right hand occurred first
as part of predominantly motor seizures, then also as inde-
pendent somatosensory seizures that were gradually
replaced by an identical continuous symptomatology. This
after unsuccessful treatments with carbamazepine and topi-
ramate was controlled by phenobarbital, whereas brief focal
myoclonic seizures continued.
Epileptiform EEG during clinically suspected somatosen-
sory EPC confirmed the diagnosis in the other three cases.
The visual symptoms in our four cases were: continuous
whitish photomes at the outer rim of the visual field contra-
lateral to an operated hemangioma, with unrevealing EEG
but sometimes evolving into a complex partial seizure via a
gradual expansion of more complex photomes over the
entire visual field; photomes of lines and circles accompa-
nied by left occipital runs of spikes; flicker in the left visual
field which had at first occurred as an isolated focal visual
seizure with right occipital epileptiform EEG activity, then
as an aura to secondarily generalized tonic–clonic (sGTC)
seizures, then in identical perception as a persistent EPC;
and a similar development leading up to repetitive 1–2 h
episodes of EPC with nonspecific focal ictal EEG abnorma-
lities and a contralateral unspecified occipital MR lesion.
If, therefore, the EEG may confirm the diagnosis, it can-
not always be relied upon. In a case of visual EPC reported
by Wolf (1980), which started with simple photomes and
evolved into complex visual hallucinations accompanied by
fragmentary versive seizures of eyes and head, the EEG
showed no epileptiform activity but contralateral occipital
slow activity and repetitive bouts of ictal nystagmus. At the
other end of the spectrum, a focal electrographic status epi-
lepticus persisting over >3 years, with a hypermetabolic
focus in the fluorodeoxyglucose–PET (FDG-PET) but with-
out any clinical signs and symptoms, has been described by
Sheth and Riggs (1999). One of the problems of EEG diag-
nostics of EPC is that the technician taking the EEG and
interacting directly with the patient may not be aware of this
diagnostic possibility and, therefore, may miss important
information. The prospective study needs to use a uniform
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EEG protocol including standardized tests for the clinical
condition.
That only these types of EPC were identified in our case
collection does not indicate that others do not exist. They
may be rare or have remained undiagnosed due to the factors
discussed. Reports exist of auditory (Wolf, 1983), gustatory
(Wieser et al., 1985; Seshia &McLachlan, 2005), and olfac-
tory (Wolf, 1982; Manford & Shorvon, 1992) EPC, and
Scott and Masland (1953) described a continuous aura con-
sisting of a distortion of proprioception or ‘‘somatognostic
illusion’’ (Mauguire & Courjon, 1978). The prospective
study will attempt to pay special attention to these less well-
known possibilities.
Etiology and pathogenesis
Unlike previous series (Thomas et al., 1977; Cockerell
et al., 1996; Gurer et al., 2001; Sinha & Satishchandra,
2007) we did not include all etiologies but focused on what
remains when the two well-known entities, that is, Rasmus-
sen syndrome and stroke-related EPC, are left out. Minus
these, the present series is the largest, and the participation
of 19 centers with access to diverse selections of patients
provided broad etiopathogenetic variability. However,
fewer varieties are represented than reviewed by Schomer
(1993) and by Wieser and Chauvel (2008), which indicates
still some recruitment bias. This series does not include
EPC in patients with impaired consciousness, which made
up for 11 of the 32 patients in the study of Thomas et al.
(1977), or of subacute sclerosing panencephalitis (SSPE) of
which Gurer et al. (2001) had three cases in a series of 21. It
is, therefore, hoped that still more groups representing a
broader range of catchment join the prospective study.
That EPC is not only observed with strictly localized
pathologies but also with systemic, especially toxic and
metabolic conditions, has long been known (Singh &
Strobos, 1980; Bien & Elger, 2008). EPC in morbus
Alpers of which our series contains five examples, was
also found in the series of Cockerell et al. (1996). EPC in
mitochondrial diseases was reported by Andermann et al.
(1986) and Sinha and Satishchandra (2007). EPC in
benign rolandic childhood epilepsy was described by
Fejerman and Di Blasi (1987), and Colamaria et al.
(1991) reported another case presenting as anterior oper-
cular syndrome, like two in our series. The third occurred
in an otherwise absolutely unremarkable and fully remit-
ting patient.
The nine patients with motor EPC due to tick-borne Rus-
sian spring-summer encephalitis form an interesting sub-
group in this study. Seven of them have been published
before in Russian language (Mukhin et al., 2006). This eti-
ology of EPC has been discussed since the late 1930s, and
was established by Chumakov (1944), who identified the
virus in the brains of patients with EPC and transferred the
encephalitis to laboratory animals. All our patients belong
to the primary type 3, even if the onset was in the acute
phase of meningoencephalitis (one case). The others had
delayed onset after 1–30 months, two of them following
focal seizures in the acute encephalitic phase. At entry, EPC
had been going on from 4–13 years. It is tempting to
hypothesize that EPC in these cases is the expression of
chronic virus inclusion modifying the activity of neurons in
the motor cortex.
The rate of unclarified etiologies would probably
be lower if optimal investigation protocols would have
been used throughout. A standardized imaging protocol
will be an indispensible feature of the planned prospective
study.
External modification
An interesting feature is the occurrence of reflex epileptic
seizure precipitation. This has repeatedly been noted before
(Thomas et al., 1977; Obeso et al., 1985; Sinha & Satishch-
andra, 2007) and was reported in 36.9% of our patients, the
trigger usually being real or intended motor activity, propri-
oception of movement, and touch. Thomas et al. (1977) also
reported the counterpart, that is, reduction or disappearance
of EPC by rest or sleep but did not mention if both occurred
in the same patients as we saw in most cases with EPC due
to tick-borne encephalitis. It remains to be seen if this is a
specific feature of this etiology or expresses a particular
interest of the reporting coauthor (KM) in these mecha-
nisms. The inhibition of EPC by strong innervation has
not been described before, whereas spike suppression by
movement in sensorimotor cortical epilepsy has recently
been demonstrated by Yanagisawa et al. (2009), and preci-
pitation or inhibition by the same stimuli as two related
variants of external modification of seizure activity was
established as a principle by Guaranha et al. (2009). That
the either precipitating or inhibitory effect of touching
a trigger zone in one of our patients depended on the timing
of the stimulus was described in detail by Wolf and
Dockweiler (1989).
Treatment
The study confirms that EPC is a pharmacoresistant con-
dition. However, an at least temporary response to ben-
zodiazepines is not rare, and a number of successful
individual schedules have been reported (Table 5). Our ear-
lier observation that topiramate is often successful in EPC
with dysontogenetic etiologies (Wolf et al., 2009) is con-
firmed, and levetiracetam in this larger study appears as
another possible treatment of choice. A positive effect of
intravenous levetiracetam was recently reported by Eggers
et al. (2009).
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